logo
Select company
Select metric
0.84Cash Ratio
VS
Market
63
Sector
37
Industry
23
History
20
$ 0.69Close
$ 0.43 - $ 2.87 52-Week Range
Ticker Information

Ticker

SGMO

Company Name

SANGAMO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SANGAMO THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SGMO - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 39.84M0.84$ 47.66M
3/31/2025$ 26.68M0.54$ 49.56M
12/31/2024$ 43.42M0.95$ 45.8M
9/30/2024$ 40.7M0.94$ 43.16M
6/30/2024$ 27.79M0.71$ 39.01M
3/31/2024$ 55.33M1.38$ 40.24M
12/31/2023$ 46.7M0.98$ 47.73M
9/30/2023$ 58.01M1.2$ 48.48M
6/30/2023$ 68.33M1.27$ 53.79M
3/31/2023$ 79.74M1.38$ 57.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SANGAMO THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 2.11.
  • Over the past 5 years, SANGAMO THERAPEUTICS INC's average Cash Ratio has been 1.09.
  • The median Cash Ratio for SANGAMO THERAPEUTICS INC during this period was 0.99
  • SANGAMO THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 2.11.
  • The lowest Cash Ratio recorded by SANGAMO THERAPEUTICS INC in the same timeframe 0.54

SANGAMO THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
ALEC : ALECTOR INC 0.55BDTX : BLACK DIAMOND THERAPEUTICS INC 1.83THTX : THERATECHNOLOGIES INC 0.24AGEN : AGENUS INC 0.04ENTA : ENANTA PHARMACEUTICALS INC 1.01PLX : PROTALIX BIOTHERAPEUTICS INC 0.74SPRO : SPERO THERAPEUTICS INC 2.09CSBR : CHAMPIONS ONCOLOGY INC 0.45TRDA : ENTRADA THERAPEUTICS INC 3.86CELU : CELULARITY INC 0.16

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for SANGAMO THERAPEUTICS INC is calculated as follows: CashnEq [ $ 260.89M ] / LiabilitesC [ $ 123.56M ]
(=) Cash Ratio [ 2.11 ]

SGMO - Cash Ratio, Last 5 years

0.54

Minimum

Mar 31, 2025

2.11

Maximum

Sep 30, 2020

1.09

Average

0.99

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63